These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

93 related items for PubMed ID: 17127728

  • 1. Morphoproteomic demonstration of constitutive nuclear factor-kappaB activation in glioblastoma multiforme with genomic correlates and therapeutic implications.
    Brown RE, Law A.
    Ann Clin Lab Sci; 2006; 36(4):421-6. PubMed ID: 17127728
    [Abstract] [Full Text] [Related]

  • 2. Morphoproteomic profile of mTOR, Ras/Raf kinase/ERK, and NF-kappaB pathways in human gastric adenocarcinoma.
    Feng W, Brown RE, Trung CD, Li W, Wang L, Khoury T, Alrawi S, Yao J, Xia K, Tan D.
    Ann Clin Lab Sci; 2008; 38(3):195-209. PubMed ID: 18715846
    [Abstract] [Full Text] [Related]

  • 3. Nuclear factor-kappaB activation and differential expression of survivin and Bcl-2 in human grade 2-4 astrocytomas.
    Angileri FF, Aguennouz M, Conti A, La Torre D, Cardali S, Crupi R, Tomasello C, Germanò A, Vita G, Tomasello F.
    Cancer; 2008 May 15; 112(10):2258-66. PubMed ID: 18327814
    [Abstract] [Full Text] [Related]

  • 4. Expression of the constitutively activated RelA/NF-kappaB in human astrocytic tumors and the in vitro implication in the regulation of urokinase-type plasminogen activator, migration, and invasion.
    Tsunoda K, Kitange G, Anda T, Shabani HK, Kaminogo M, Shibata S, Nagata I.
    Brain Tumor Pathol; 2005 May 15; 22(2):79-87. PubMed ID: 18095109
    [Abstract] [Full Text] [Related]

  • 5. Morphoproteomic confirmation of constitutively activated mTOR, ERK, and NF-kappaB pathways in high risk neuro-blastoma, with cell cycle and protein analyte correlates.
    Brown RE, Tan D, Taylor JS, Miller M, Prichard JW, Kott MM.
    Ann Clin Lab Sci; 2007 May 15; 37(2):141-7. PubMed ID: 17522369
    [Abstract] [Full Text] [Related]

  • 6. [DNA binding activity of nuclear factor-kappa B in human astrocytoma].
    Guo CB, Chen F, Gao ZW.
    Ai Zheng; 2004 Oct 15; 23(10):1207-9. PubMed ID: 15473937
    [Abstract] [Full Text] [Related]

  • 7. Integrin involvement in glioblastoma multiforme: possible regulation by NF-kappaB.
    Ritchie CK, Giordano A, Khalili K.
    J Cell Physiol; 2000 Aug 15; 184(2):214-21. PubMed ID: 10867646
    [Abstract] [Full Text] [Related]

  • 8. Magnolol suppresses NF-kappaB activation and NF-kappaB regulated gene expression through inhibition of IkappaB kinase activation.
    Tse AK, Wan CK, Zhu GY, Shen XL, Cheung HY, Yang M, Fong WF.
    Mol Immunol; 2007 Apr 15; 44(10):2647-58. PubMed ID: 17240450
    [Abstract] [Full Text] [Related]

  • 9. Aberrant constitutive activation of nuclear factor kappaB in glioblastoma multiforme drives invasive phenotype.
    Raychaudhuri B, Han Y, Lu T, Vogelbaum MA.
    J Neurooncol; 2007 Oct 15; 85(1):39-47. PubMed ID: 17479228
    [Abstract] [Full Text] [Related]

  • 10. Mullerian-inhibiting substance induces Gro-beta expression in breast cancer cells through a nuclear factor-kappaB-dependent and Smad1-dependent mechanism.
    Gupta V, Yeo G, Kawakubo H, Rangnekar V, Ramaswamy P, Hayashida T, MacLaughlin DT, Donahoe PK, Maheswaran S.
    Cancer Res; 2007 Mar 15; 67(6):2747-56. PubMed ID: 17363596
    [Abstract] [Full Text] [Related]

  • 11. Berberine modifies cysteine 179 of IkappaBalpha kinase, suppresses nuclear factor-kappaB-regulated antiapoptotic gene products, and potentiates apoptosis.
    Pandey MK, Sung B, Kunnumakkara AB, Sethi G, Chaturvedi MM, Aggarwal BB.
    Cancer Res; 2008 Jul 01; 68(13):5370-9. PubMed ID: 18593939
    [Abstract] [Full Text] [Related]

  • 12. Activation of the NF-kappaB signalling pathway in diffuse large B-cell lymphoma: clinical implications.
    Espinosa I, Briones J, Bordes R, Brunet S, Martino R, Sureda A, Sierra J, Prat J.
    Histopathology; 2008 Oct 01; 53(4):441-9. PubMed ID: 18983609
    [Abstract] [Full Text] [Related]

  • 13. Methylglyoxal suppresses TNF-alpha-induced NF-kappaB activation by inhibiting NF-kappaB DNA-binding.
    Laga M, Cottyn A, Van Herreweghe F, Vanden Berghe W, Haegeman G, Van Oostveldt P, Vandekerckhove J, Vancompernolle K.
    Biochem Pharmacol; 2007 Aug 15; 74(4):579-89. PubMed ID: 17617381
    [Abstract] [Full Text] [Related]

  • 14. Activation of p38 MAPK in the substantia nigra leads to nuclear translocation of NF-kappaB in MPTP-treated mice: implication in Parkinson's disease.
    Karunakaran S, Ravindranath V.
    J Neurochem; 2009 Jun 15; 109(6):1791-9. PubMed ID: 19457134
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Attenuation of monocyte chemoattractant protein-1 expression via inhibition of nuclear factor-kappaB activity in inflammatory vascular injury.
    Gao X, Iwai M, Inaba S, Tomono Y, Kanno H, Mogi M, Horiuchi M.
    Am J Hypertens; 2007 Nov 15; 20(11):1170-5. PubMed ID: 17954363
    [Abstract] [Full Text] [Related]

  • 17. Molecular basis of nuclear factor-kappaB activation by astrocyte elevated gene-1.
    Sarkar D, Park ES, Emdad L, Lee SG, Su ZZ, Fisher PB.
    Cancer Res; 2008 Mar 01; 68(5):1478-84. PubMed ID: 18316612
    [Abstract] [Full Text] [Related]

  • 18. NF-kappaB activates transcription of the RNA-binding factor HuR, via PI3K-AKT signaling, to promote gastric tumorigenesis.
    Kang MJ, Ryu BK, Lee MG, Han J, Lee JH, Ha TK, Byun DS, Chae KS, Lee BH, Chun HS, Lee KY, Kim HJ, Chi SG.
    Gastroenterology; 2008 Dec 01; 135(6):2030-42, 2042.e1-3. PubMed ID: 18824170
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. 1,25-dihydroxyvitamin D3 induces biphasic NF-kappaB responses during HL-60 leukemia cells differentiation through protein induction and PI3K/Akt-dependent phosphorylation/degradation of IkappaB.
    Tse AK, Wan CK, Shen XL, Zhu GY, Cheung HY, Yang M, Fong WF.
    Exp Cell Res; 2007 May 01; 313(8):1722-34. PubMed ID: 17397830
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.